Skip to main content


Cardiovascular Disease

Department Investigators

Janet D. Sparks Atherosclerosis
James Corsetti Atherosclerosis
Faqian Li Cell signaling in cardiac development, hypertrophy, and failure
Bruce Goldman Cardiovascular disease and cardiac transplant
Ming Qi Long QT syndrome
Peter J. Sims Molecular mechanisms of inflammation and thrombosis
Therese Wiedmer Molecular mechanisms of inflammation and thrombosis
Chawnshang Chang Androgen receptor role in myocardial repair

Current Awards

Faqian Li Beta-catenin and cardiac chamber remodeling during late heart development (American Heart Association)

Interdepartmental Collaborations


Bradford Berk Cardiovascular disease
Joseph Miano Cardiovascular disease
Arthur Moss Long QT syndrome, thrombogenic blood markers
Wojciech Zareba Thrombogenic blood markers


Peter Salzman Beyesian network analysis

Southwest Foundation for Biomedical Research

David Rainwater Thrombogenic blood markers

University of Groningen, The Netherlands

Robin Dullaart PREVEND (Prevention of Renal and Vascular End-Stage Disease) study

Educational Opportunities

  • PhD program thesis opportunities in cardiovascular and endocrine disease

Clinical Highlights

  • Cardiac pathologists: Bruce Goldman, Faqian Li
  • Heart failure and transplantation center
  • Clinical chemistry laboratory offers assays for cardiac markers using a variety of chemical and immunochemical methodologies
  • Immunohistochemical analysis: ER, PR, HER2 and Ki-67 for guiding targeted therapy; EGFR and CK5/6 for molecular classification
  • The cardiac pathology team is highly experienced in the interpretation of endomyocardial biopsies from both cardiac allografts and native hearts and other surgical pathology specimens obtained from the heart and blood vessels